Source:http://linkedlifedata.com/resource/pubmed/id/17631184
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-7-16
|
pubmed:abstractText |
The aim of hematopoietic stem cell transplantation (HSCT) is to cure patients of malignancies, autoimmune diseases, and immunodeficiency disorders by redirecting the immune system: the often described graft-versus-leukemia (GVL) or graft-versus-tumor (GVT) effects. Unfortunately, fulfillment of this goal is often hampered by relapse of the underlying disease, graft-versus-host disease (GVHD), or severe opportunistic infections, which account for the majority of post-transplantation deaths. Moreover, studies of long-term survivors of transplantation indicate an accelerated immune aging due to the transplantation procedure itself, preceding chemo- or radiotherapy, and acute and chronic GVHD. Significant advances have been made towards overcoming these obstacles by enhancing immune reconstitution with hematopoietic growth factors (HGFs) such as granulocyte colony-stimulating factor (G-CSF) or erythropoietin (EPO) or through the application of cytokines. In addition, there are approaches to promote the thymic-dependent development of naive T cells, which are prepared for the interaction with a multitude of pathogens. Examples are the application of keratinocyte growth factor (KGF), neuroendocrine hormones such as growth hormone or prolactin, sex hormone ablation, or the invention of a three-dimensional artificial thymus based on a cytomatrix. Might these measures result in a higher rate of healthy and fully recovered patients? Here we review progress in each of these areas.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 7,
http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating...,
http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte-Macrophage...,
http://linkedlifedata.com/resource/pubmed/chemical/Hematopoietic Cell Growth Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0037-1963
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
203-11
|
pubmed:meshHeading |
pubmed-meshheading:17631184-Animals,
pubmed-meshheading:17631184-Autoimmune Diseases,
pubmed-meshheading:17631184-Fibroblast Growth Factor 7,
pubmed-meshheading:17631184-Graft vs Host Disease,
pubmed-meshheading:17631184-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:17631184-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:17631184-Hematopoietic Cell Growth Factors,
pubmed-meshheading:17631184-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:17631184-Humans,
pubmed-meshheading:17631184-Immune System,
pubmed-meshheading:17631184-Neoplasms,
pubmed-meshheading:17631184-Thymus Gland,
pubmed-meshheading:17631184-Transplantation, Autologous,
pubmed-meshheading:17631184-Transplantation, Homologous
|
pubmed:year |
2007
|
pubmed:articleTitle |
Hematopoietic growth factors including keratinocyte growth factor in allogeneic and autologous stem cell transplantation.
|
pubmed:affiliation |
Department of Internal Medicine II, Julius-Maximilians-University, Würzburg, Germany.
|
pubmed:publicationType |
Journal Article,
Review
|